Think Beyond Different, Way Beyond Different.™
D’OXYVA® (deoxyhemoglobin vasodilator) is the first biotech solution of its kind. D’OXYVA is clinically validated to significantly improve microcirculation, which is an effective treatment option for many conditions.
D’OXYVA biotechnology provides an inexpensive and simple method of solving the longstanding problem of delivering medication to the bloodstream through needles, which are highly invasive, or oral delivery, which often results in gastrointestinal (GI) tract absorption issues and loss of most of the active ingredients in medication.
It only takes an average of 5 minutes per application.
HOW CAN D’OXYVA HELP?
D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.
The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.
Based on years of experience, D’OXYVA has continued developing microcirculation therapy. This process, unique to D’OXYVA, has demonstrated triggering protective physiological functions in the body: vasodilation and vasoconstrictions in the vessels, catalyzing vessel structure growth (angiogenesis), autoregulation of local blood supply in tissues and organs, neuroreceptor signaling in the brain and balancing blood pH, among other critical functions.